Exscientia Plc - American Depositary Shares (NQ:EXAI)

4.840 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exscientia Plc - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Exscientia to Present at Upcoming Investor Conferences in March

February 22, 2022

From Exscientia

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 18, 2022

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stoc...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 07, 2022

Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22....

Via Benzinga

"Our Mission Is To Eliminate Cancer" – Here's How This Company Is Using AI In An Attempt To Save Lives ↗

January 26, 2022

Photo by National Cancer Institute on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Three Analysts Initiate Coverage On This AI-Based Pharmatech ↗

October 26, 2021

BofA

Via Benzinga

Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI

January 19, 2022

From Exscientia

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million....

Via Benzinga

Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines

January 07, 2022

From Exscientia

Via Business Wire

Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference

November 23, 2021

From Exscientia

Via Business Wire

Exscientia Business Update for Third Quarter 2021

November 17, 2021

From Exscientia

Via Business Wire

Earnings Scheduled For November 17, 2021 ↗

November 17, 2021

Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion....

Via Benzinga

Exscientia to Report Third Quarter 2021 Financial Results on November 17, 2021

November 10, 2021

From Exscientia

Via Business Wire

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes

October 11, 2021

From Exscientia

Via Business Wire

Exscientia Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters’ Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

October 05, 2021

From Exscientia

Via Business Wire

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 05, 2021

Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

Exscientia Announces Pricing of $304.7 Million Upsized Initial Public Offering and $160.0 Million Concurrent Private Placements

September 30, 2021

From Exscientia plc Exscientia

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.